Crank CRM ^Company

Valence Discovery to Support Repare Therapeutics on AI-Enabled Drug Discovery in Precision Oncology MONTREAL and CAMBRIDGE, Mass., March 17, 2021 --Valence Discovery (Valence), an emerging leader in AI-enabled drug design, today announced it has entered into a drug discovery agreement with Repare Therapeutics (Repare, Nasdaq: RPTX), a precision oncology company pioneering ...